For The Latest Medical News, Health News, Research News, COVID-19 News, Pharma News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Thailand Cannabis News, Cancer News, Doctor News, Thailand Hospital News, Oral Cancer News, Thailand Doctors

BREAKING NEWS
Nikhil Prasad  Fact checked by:Thailand Medical News Team May 21, 2025  8 hours, 20 minutes ago

PQ.2 - The Spawn of NB.1.8.1 - The New SARS-CoV-2 Super Variant with Potential to Spread Like Wildfire - Are We Ready for the Next Wave?

8212 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
PQ.2 - The Spawn of NB.1.8.1 - The New SARS-CoV-2 Super Variant with Potential to Spread Like Wildfire - Are We Ready for the Next Wave?
Nikhil Prasad  Fact checked by:Thailand Medical News Team May 21, 2025  8 hours, 20 minutes ago
Medical News: A New Contender Emerges in the SARS-CoV-2 Lineage
On May 20, 2025, variant hunter Dr Xu Zou from Tsinghua Univeristy(@xz_keg) dropped a bombshell on X, announcing the rise of a new SARS-CoV-2 sub-lineage, designated PQ.2, within the NB.1.8.1 family. This variant, which has already reached a staggering 30% prevalence in Hong Kong, is outpacing its parent strain by 30%, raising alarm bells among global health experts. The defining mutation, Orf3a:W193R, is a game-changer, potentially altering the virus's behavior in ways that could challenge existing immunity and treatment strategies.
https://x.com/xz_keg/status/1924823218554339654
 
https://github.com/sars-cov-2-variants/lineage-proposals/issues/2559


PQ.2 - The Spawn of NB.1.8.1 - The New SARS-CoV-2 Super Variant with Potential to Spread Like
Wildfire - Are We Ready for the Next Wave?


What Makes PQ.2 So Concerning?
According to this Medical News report, PQ.2’s rapid spread is fueled by its 38% growth advantage over other NB.1.8.1 sub-lineages, as illustrated in a detailed graph shared by Zou. The variant’s key mutation, Orf3a:W193R, mirrors a residue found in SARS-CoV-1, known to significantly alter the Orf3a protein’s function.

This protein plays a critical role in viral infection and immune evasion, and the W193R mutation may enhance the virus’s ability to dodge immune responses.
https://www.sciencedirect.com/science/article/pii/S2405580821000273

Additionally, a convergent mutation, Orf3a:S171L, further complicates the picture, as both residues are pivotal in distinguishing the functional differences between SARS-CoV-1 and SARS-CoV-2.
 
Global Spread and Implications
PQ.2 has already been detected in multiple regions, including Canada, Germany, Singapore, South Korea, and the USA, with sequences dating back to March 9, 2025, in Hong Kong. Its rapid adaptation, as noted by X user @Nosey_MF
, suggests a "racehorse" evolution, potentially driven by immune pressure or increased transmissibility. The variant’s 24% estimated increase in transmissibility, per Zou’s data, could signal a new wave of infections, especially in regions like South-east Asia, already grappling with a surge in COVID-19 cases.
 
Are We Prepared for What’s Next?
As PQ.2 continues its global march, the question remains: are we ready? Health authorities must ramp up genomic surveillance and research to understand this variant’s impact on vaccine efficacy and therapeutics. The world watches with bated breath as PQ.2 races ahead—potentially heralding the next chapter in the ongoing pandemic s aga.
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/nb-1-8-1-the-new-sars-cov-2-variant-racing-to-dominate-is-a-new-wave-coming
 
https://www.thailandmedical.news/news/new-sars-cov-2-variants-xfg-xfc-and-nb-1-8-1-likely-to-lead-summer-covid-19-surge-across-the-united-states
 
https://www.thailandmedical.news/news/breaking-the-new-sars-cov-2-variant-nb-1-8-1-is-the-most-dangerous-so-far-and-poses-a-major-threat
 
https://www.thailandmedical.news/articles/coronavirus
 
https://www.thailandmedical.news/pages/thailand_doctors_listings
 

MOST READ

Mar 10, 2025  2 months ago
Nikhil Prasad
Mar 01, 2025  3 months ago
Nikhil Prasad
Feb 17, 2025  3 months ago
Nikhil Prasad
Dec 11, 2024  5 months ago
Nikhil Prasad